Zobrazeno 1 - 4
of 4
pro vyhledávání: '"MSMD, Mendelian susceptibility to mycobacterial disease"'
Autor:
Majid Yaran, Daniel Kotlarz, Vajihe Ostadi, Christoph Klein, Mahdieh Behnam, Razieh Khoshnevisan, Roya Sherkat, Nioosha Nekooei-marnany, Abbas Rezaei
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 17, Iss, Pp-(2019)
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Background: The interleukin-12 receptor β1 (IL-12Rβ1) deficiency is a primary immunodeficiency (PID), affecting the immunological pathway of interleukin 12/interferon- γ (IL12/IFN-γ) axis and interleukin 23 receptor (IL23R). Defect in this pathwa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36434be8cc98fe856d2967f094589172
http://www.sciencedirect.com/science/article/pii/S2405579419300646
http://www.sciencedirect.com/science/article/pii/S2405579419300646
Publikováno v:
Cytokine & Growth Factor Reviews
Interferons (IFN) are key cytokines with multifaceted antiviral and cell-modulatory properties. Three distinct types of IFN are recognized (I-III) based on structural features, receptor usage, cellular source and biological activities. The action of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b33f9602425b8aa361d19eb4ee80b9
http://europepmc.org/articles/PMC7108279
http://europepmc.org/articles/PMC7108279
Publikováno v:
Vaccine
A major limitation in the development and testing of new tuberculosis (TB) vaccines is the current inadequate understanding of the nature of the immune response required for protection against either infection with Mycobacterium tuberculosis (MTB) or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c497de16b52875e7a6ef23cd22f16dc
https://pubmed.ncbi.nlm.nih.gov/26006085
https://pubmed.ncbi.nlm.nih.gov/26006085
Autor:
Khoshnevisan R; Immunology Department, Isfahan University of Medical Sciences, Isfahan, Iran., Nekooei-Marnany N; Aquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran., Klein C; Dr. von Hauner Children's Hospital, Department of Pediatrics, University Hospital, LMU Munich, Munich, Germany., Kotlarz D; Dr. von Hauner Children's Hospital, Department of Pediatrics, University Hospital, LMU Munich, Munich, Germany., Behnam M; Immunology Department, Isfahan University of Medical Sciences, Isfahan, Iran., Ostadi V; Immunology Department, Isfahan University of Medical Sciences, Isfahan, Iran.; Aquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran., Yaran M; Aquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran., Rezaei A; Immunology Department, Isfahan University of Medical Sciences, Isfahan, Iran.; Aquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran., Sherkat R; Aquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Publikováno v:
Journal of clinical tuberculosis and other mycobacterial diseases [J Clin Tuberc Other Mycobact Dis] 2019 Sep 20; Vol. 17, pp. 100123. Date of Electronic Publication: 2019 Sep 20 (Print Publication: 2019).